Paul W. Hoelscher - Jan 21, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, CFO
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Jan 21, 2022
Transactions value $
-$212,852
Form type
4
Date filed
1/24/2022, 04:06 PM
Previous filing
Jan 24, 2022
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $0 +5.56K +8.61% $0.00 70.1K Jan 21, 2022 Direct
transaction HZNP Ordinary Shares Tax liability -$213K -2.46K -3.51% $86.42 67.7K Jan 21, 2022 Direct
holding HZNP Ordinary Shares 178K Jan 21, 2022 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSUs) Options Exercise $0 -5.56K -100% $0.00* 0 Jan 21, 2022 Ordinary Shares 5.56K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed on behalf of the Reporting Person on January 6, 2022 inadvertently reported this amount as 178,839.
F2 Each RSU represents a contingent right to receive one ordinary share of the Issuer.